Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
0.620
+0.020 (3.30%)
At close: Jun 26, 2026, 4:00 PM EDT
0.610
-0.010 (-1.55%)
After-hours: Jun 26, 2026, 7:22 PM EDT
Gelteq Employees
As of June 30, 2025, Gelteq had 8 total employees, including 7 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$33,857
Profits / Employee
-$544,602
Market Cap
6.64M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 8 | 0 | - |
| Jun 30, 2024 | 8 | 0 | - |
| Jun 30, 2023 | 8 | 5 | 166.67% |
| Jun 30, 2021 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Biofrontera | 94 |
| China SXT Pharmaceuticals | 75 |
| Sunshine Biopharma | 50 |
| cbdMD | 42 |
| InMed Pharmaceuticals | 13 |
| RedHill Biopharma | 13 |
| Sonoma Pharmaceuticals | 10 |
| PRF Technologies | 7 |
GELS News
- 10 days ago - Gelteq Transcript: Planet MicroCap Las Vegas 2026 - Transcripts
- 10 days ago - Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs - GlobeNewsWire
- 15 days ago - Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications - GlobeNewsWire
- 23 days ago - Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion - GlobeNewsWire
- 5 weeks ago - Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway - GlobeNewsWire
- 6 weeks ago - Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA - Accesswire
- 6 weeks ago - Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth - GlobeNewsWire
- 2 months ago - Healthy Extracts Reports 2025 Net Revenue Up 45% to Record $4.5 Million - Accesswire